CA3225855A1 - Treatment of varicose veins with piezo type mechanosensitive ion channel component 1 (piezo1) agonists - Google Patents
Treatment of varicose veins with piezo type mechanosensitive ion channel component 1 (piezo1) agonists Download PDFInfo
- Publication number
- CA3225855A1 CA3225855A1 CA3225855A CA3225855A CA3225855A1 CA 3225855 A1 CA3225855 A1 CA 3225855A1 CA 3225855 A CA3225855 A CA 3225855A CA 3225855 A CA3225855 A CA 3225855A CA 3225855 A1 CA3225855 A1 CA 3225855A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- complement
- position corresponding
- piez01
- uracil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163219462P | 2021-07-08 | 2021-07-08 | |
| US63/219,462 | 2021-07-08 | ||
| PCT/US2022/073441 WO2023283560A1 (en) | 2021-07-08 | 2022-07-05 | Treatment of varicose veins with piezo type mechanosensitive ion channel component 1 (piezo1) agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3225855A1 true CA3225855A1 (en) | 2023-01-12 |
Family
ID=82748409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3225855A Pending CA3225855A1 (en) | 2021-07-08 | 2022-07-05 | Treatment of varicose veins with piezo type mechanosensitive ion channel component 1 (piezo1) agonists |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230041060A1 (https=) |
| EP (1) | EP4367266A1 (https=) |
| JP (1) | JP2024524554A (https=) |
| KR (1) | KR20240049797A (https=) |
| CN (1) | CN121175436A (https=) |
| AU (1) | AU2022307546A1 (https=) |
| CA (1) | CA3225855A1 (https=) |
| IL (1) | IL309694A (https=) |
| MX (1) | MX2023015276A (https=) |
| WO (1) | WO2023283560A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK4317456T3 (da) * | 2019-02-18 | 2025-09-08 | Regeneron Pharma | Varianter af mekanoensitiv ionkanalkomponent 1 af piezotypen (piezo1) og anvendelser deraf |
-
2022
- 2022-07-05 EP EP22748705.5A patent/EP4367266A1/en active Pending
- 2022-07-05 KR KR1020247004214A patent/KR20240049797A/ko active Pending
- 2022-07-05 CA CA3225855A patent/CA3225855A1/en active Pending
- 2022-07-05 IL IL309694A patent/IL309694A/en unknown
- 2022-07-05 WO PCT/US2022/073441 patent/WO2023283560A1/en not_active Ceased
- 2022-07-05 US US17/810,820 patent/US20230041060A1/en active Pending
- 2022-07-05 AU AU2022307546A patent/AU2022307546A1/en active Pending
- 2022-07-05 JP JP2024500281A patent/JP2024524554A/ja active Pending
- 2022-07-05 CN CN202280060862.6A patent/CN121175436A/zh active Pending
- 2022-07-05 MX MX2023015276A patent/MX2023015276A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023283560A1 (en) | 2023-01-12 |
| MX2023015276A (es) | 2024-04-03 |
| JP2024524554A (ja) | 2024-07-05 |
| EP4367266A1 (en) | 2024-05-15 |
| AU2022307546A1 (en) | 2024-01-04 |
| IL309694A (en) | 2024-02-01 |
| CN121175436A (zh) | 2025-12-19 |
| US20230041060A1 (en) | 2023-02-09 |
| KR20240049797A (ko) | 2024-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240102013A1 (en) | Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) Inhibitors | |
| CA3191030A1 (en) | Treatment of sepsis with pcsk9 and ldlr modulators | |
| US20230000897A1 (en) | Treatment Of Cerebrovascular Disease With Neurogenic Locus Notch Homolog Protein 3 (NOTCH3) Agents | |
| CA3225855A1 (en) | Treatment of varicose veins with piezo type mechanosensitive ion channel component 1 (piezo1) agonists | |
| WO2022261341A1 (en) | Treatment of psoriasis with interferon induced helicase c domain 1 (ifih1) inhibitors | |
| US12186378B2 (en) | Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists | |
| CA3141632A1 (en) | Treatment of decreased bone mineral density with zinc and ring finger 3 (znrf3) inhibitors | |
| EP4114975B1 (en) | Fascin-2 (fscn2) variant and use thereof | |
| US12070460B2 (en) | Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors | |
| US20210371930A1 (en) | Solute Carrier Family 26 Member 5 (SLC26A5) Variants And Uses Thereof | |
| CA3222828A1 (en) | Treatment of hypertension with solute carrier family 9 isoform a3 regulatory factor 2 (slc9a3r2) inhibitors | |
| US20230034093A1 (en) | Treatment Of Cognitive Impairment With Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 5 (ST6GALNAC5) Inhibitors | |
| CA3141309A1 (en) | Synaptojanin 2 (synj2) variants and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250625 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250625 |